학술논문
Safety and efficacy of consolidative stereotactic radiotherapy for oligo-residual EGFR-mutant non-small cell lung cancer after first-line third-generation EGFR-tyrosine kinase inhibitors: a single-arm, phase 2 trial
Document Type
Article
Author
Source
In eClinicalMedicine October 2024 76
Subject
Language
ISSN
2589-5370